GSK Q1 2026 Earnings Solid EPS Beat Amid Mixed Market Sentiment Cartesian Therapeutics Inc RNAC Q1 2026 Earnings ClinicalStage Biotech Reports WiderThanExpected Loss Stock Ticks Higher ERAS Q1 2026 Earnings EPS Misses Estimates by Wide Margin Shares Decline 315 Lixte Biotechnology Holdings Inc LIXT Q4 2024 Earnings Net Loss of 027 Per Share as Pipeline Progress Continues LGND Q1 2026 Earnings Earnings Miss Weighed Against Upbeat Strategic Progress EDUC Q1 2026 Earnings Narrowing Loss Highlights Ongoing Restructuring